Eoin P. Beirne
Member / Co-chair, White Collar Defense and Government Investigations Practice
+1.617.348.1707
Eóin is an accomplished white collar defense lawyer who resourcefully shepherds individual and corporate clients through government investigations and enforcement proceedings. He represents clients in a wide variety of industries in state and federal courts and before an array of investigative and enforcement bodies. Eóin routinely represents Boards of Directors or Board committees conducting internal investigations. He counsels clients on a variety of matters including wire and mail fraud, health care fraud, public corruption, insider trading, and violations of the False Claims Act and the Foreign Corrupt Practices Act.
Eóin has successfully tried cases in federal and state courts and represents clients dealing with the DOJ, SEC, State Attorneys General, OIGs, FINRA and other regulatory and enforcement bodies.
Eóin has conducted numerous internal investigations both at the client’s own initiative and following receipt of a subpoena, Civil Investigative Demand or other notice of a government investigation. Eóin also advises clients responding to cyber-attacks and the Computer Fraud and Abuse Act.
Prior to joining the firm, Eóin served as a student assistant district attorney in law school, was a member of the Moot Court Executive Board, was elected to the Order of Barristers and interned for Judge Reena Raggi in the Eastern District of New York.
Education
- Brooklyn Law School (JD, cum laude)
- Trinity College (BA, Economics)
Experience
Representative Matters
- Currently representing various health care providers in connection with criminal and civil investigations.
- Currently representing an individual in connection with ongoing global investigations into 1MDB.
- Represented several elected officials with respect to grand jury investigations without any charges being brought.
- Convinced the Department of Justice not to charge or sue a number of government contractors in differing industries following investigations of alleged False Claims Act violations.
- Resolved False Claims Act investigation by the Department of Justice and Massachusetts Attorney General into urgent care clinic chain.
- Represented several diagnostic laboratories in connection with criminal and civil investigations by the Department of Justice.
- Represented pharmaceutical company in connection with SEC and DOJ insider trading investigation.
- Secured complete dismissal of charges at trial in federal court involving mail and wire fraud against an individual.
- Represented large corporation in connection with Foreign Corrupt Practice Act investigation resulting in no charges brought.
- Represented top gaming company and company executives in connection with grand jury investigation.
- Performed internal investigation for board committee in response to whistleblower complaint.
- Routinely represent individual witnesses in connection with FBI and OIG investigations.
- Represented technology company in connection with theft by former employee.
Recognition & Awards
- Best Lawyers in America: Criminal Defense: White Collar (2021-2022)
- Massachusetts Super Lawyers: Criminal Defense: White Collar (2017-2020)
- Massachusetts Super Lawyers: Rising Star – Criminal Defense: White Collar (2013 - 2016)
Involvement
- Member, Boston Bar Association
- Member, Federal Bar Association
- Past Board Member, Massachusetts Association of Criminal Defense Lawyers (MACDL)
- Member, American Bar Association’s Public Corruption and Extortion Subcommittee and the Criminal E-Discovery Taskforce
Recent Insights
Viewpoints
Health Care Enforcement Kept the DOJ Fraud Section Busy in 2020
March 8, 2021 |Blog
Webinar Recording: Health Care Enforcement Year in Review & 2021 Outlook
February 24, 2021
News & Press
Events
Despite the threat of COVID-19 paralyzing much of the country in 2020, government health care fraud enforcement continued even though the Department of Justice (DOJ) had the added burden of pursuing COVID-19 related fraud. While criminal enforcement actions involving opioids remained a top enforcement priority, the civil False Claims Act (FCA) is still one of the government’s most powerful enforcement tools. In our annual webinar, Mintz’s Health Care Enforcement Defense team will review the key policy developments, settlements, and court decisions from 2020 and assess their likely impact in 2021 and beyond.
Viewpoints
The DOJ’s Fraud Section 2020 Annual Review: Financial Enforcement Focused on Major Corporate Resolutions and Emerging COVID-19 Fraud
March 12, 2021 | Blog | By Eoin Beirne, Grady Campion
Health Care Enforcement Kept the DOJ Fraud Section Busy in 2020
March 8, 2021 | Blog | By Eoin Beirne, Grady Campion
On February 24, 2021, DOJ’s Criminal Division Fraud Section published its annual year-end summary. The Fraud Section focuses on prosecuting white-collar crime. The report summarizes enforcement activity in the past year and discusses notable cases from the Fraud Section’s three litigation units: (1) the Health Care Fraud (HCF) Unit; (2) the Foreign Corrupt Practices Act (FCPA) Unit; and (3) the Market Integrity and Major Frauds (MIMF) Unit. In summarizing the Fraud Section’s main achievements from 2020, the report also provides valuable insights on what lies ahead for the Fraud Section in 2021. This post focuses on the health care enforcement portion of the Fraud Section’s report.
Read more
Webinar Recording: Health Care Enforcement Year in Review & 2021 Outlook
February 24, 2021 | | By Eoin Beirne, Brian Dunphy, Hope Foster, Karen Lovitch
In our annual webinar, Mintz’s Health Care Enforcement Defense team reviewed the key policy developments, settlements, and court decisions from 2020 and assessed their likely impact in 2021 and beyond.
Read more
Health Care Enforcement Year in Review & 2021 Outlook
February 18, 2021 | | By Eoin Beirne, Brian Dunphy, Karen Lovitch, Kevin McGinty, Samantha Kingsbury, Keshav Ahuja, Grady Campion, Jane Haviland, Caitie Hill, Rebecca Zeidel
Despite the threat of COVID-19 paralyzing much of the country in 2020, government health care fraud enforcement continued even though the Department of Justice (DOJ) had the added burden of pursuing COVID-19 related fraud. Mintz’s Health Care Enforcement Defense team has reviewed the key policy issues, statistics, settlements, and court decisions from 2020, and in this report we reflect on those developments and also predict the trends in health care enforcement in 2021 and beyond.
Read more
FinCen Issues Statement Regarding Publication of Suspicious Activity Reports (SARs)
September 3, 2020 | Blog | By Eoin Beirne, Cory S. Flashner, Pete Michaels, Jason Burrell
On September 1, 2020, the Financial Crimes Network (“FinCEN”) issued a statement regarding various media outlets’ intent to publish Suspicious Activity Reports (“SARs”) and “other sensitive government documents”.
Read more
COVID-19 Relief Programs: Recent Criminal Enforcement and Anticipated Trends
July 9, 2020 | Blog | By Eoin Beirne, Nicole Henry
Leading up to a webinar on July 15, 2020, we are publishing a blog series covering the risks of enforcement against companies that received COVID-19 relief funds under the CARES Act and strategies for mitigating those risks. This third, and final, installment of our series discusses emerging and anticipated criminal enforcement involving COVID-19 relief programs.
Read more
Health Care Enforcement Year-in-Review and 2020 Outlook: Criminal Case Developments
January 22, 2020 | Blog | By Eoin Beirne, Nicole Henry, Jason Burrell, Jane Haviland
As discussed in our article recently published by Law360, criminal health care enforcement in 2019 was in many ways a continuation of 2018, with opioid-related enforcement continuing to be the clear top priority for the Department of Justice (DOJ), in addition to DOJ's sustained focus on prosecuting individuals and data-driven identification of health care fraud. This post provides an overview of our article, which covers these issues and our expectations for 2020 in detail.
Read more
Health Care Enforcement Year in Review & 2019 Outlook: Criminal Enforcement Trends
January 9, 2019 | Blog | By Eoin Beirne
Criminal healthcare enforcement in 2018 once again focused heavily on opioids, targeting manufacturers, prescribers, dispensers and those who contribute to the addiction epidemic, and on prosecution of individuals for a variety of offenses. In addition, the DOJ announced some expected policy changes related to the way it investigates and prosecutes corporations as well as the restrictions placed on corporations after resolution of government charges. We will address each of these issues in this post and will attempt to forecast what we expect to occur in the coming year.
Read more
Narrow Ruling for Privacy at SCOTUS in Carpenter
July 3, 2018 | Blog | By Eoin Beirne
The Supreme Court ruled, at the end of June, that seizing cell-site location information—data that tracks cell phone users’ movements—constitutes a search under the Fourth Amendment.
Read more
Health Care Enforcement Review and 2018 Outlook: Criminal and Civil Enforcement Trends
January 8, 2018 | Blog | By Eoin Beirne, Samantha Kingsbury, Karen Lovitch
In both civil and criminal enforcement proceedings, 2017 was perhaps most notable for the cases brought against individual health care providers and small physician practice owners.
Read more
News & Press
2019 Trends In DOJ Health Care Enforcement
January 13, 2020
Mintz Member Eóin Beirne and Associates Jason Burrell and Nicole Henry co-authored this Law360 expert analysis article examining trends and developments in criminal health care enforcement in 2019, such as opioid-related enforcement, kickbacks and medical necessity, medical devices, U.S. Department of Justice guidance, and more. The article also posits criminal health care enforcement trends for 2020, including the increased use of data-driven investigative tools, continued opioid prosecutions, and scrutiny of new technologies or novel ways of delivering medical care.
2017 Health Care Enforcement Review: Final Thoughts
January 19, 2018
Karen Lovitch, practice leader of the Mintz Health Law Practice, Eoin Beirne, a Member in the firm’s Litigation practice, along with Associates Samantha Kingsbury and Mackenzie Queenin authored the last in a four-part series of articles on health care enforcement trends in 2017.
Fifty-one attorneys from Mintz have been named Massachusetts Super Lawyers for 2017 and thirty have been named Massachusetts Rising Stars.
Mintz Members will be participating in multiple panel discussions at the 2017 Boston Conference on Cyber Security hosted by Boston College and the FBI. The event presents an opportunity for leading minds to come together and fashion a more secure cyberspace.
Eighty-Four Mintz Attorneys Named 2016 Massachusetts Super Lawyers and Rising Stars
October 18, 2016
Fifty-three Mintz attorneys have been named Massachusetts Super Lawyers for 2016 and thirty-one have been named Massachusetts Rising Stars. The findings will be published in the November 2016 issue of Boston Magazine and in a stand-alone magazine, New England Super Lawyers.
Events
Speaker
Speaker
Speaker
Panelist
Faculty
Panelist